145 related articles for article (PubMed ID: 27214240)
1. Predictive role of the overexpression for CXCR4, C-Met, and VEGF-C among breast cancer patients: A meta-analysis.
Wang F; Li S; Zhao Y; Yang K; Chen M; Niu H; Yang J; Luo Y; Tang W; Sheng M
Breast; 2016 Aug; 28():45-53. PubMed ID: 27214240
[TBL] [Abstract][Full Text] [Related]
2. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
Xu TP; Shen H; Liu LX; Shu YQ
Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.
Wang J; Guo Y; Wang B; Bi J; Li K; Liang X; Chu H; Jiang H
Mol Biol Rep; 2012 Dec; 39(12):11153-65. PubMed ID: 23054001
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.
Peng L; Zhan P; Zhou Y; Fang W; Zhao P; Zheng Y; Xu N
Mol Biol Rep; 2012 Oct; 39(10):9473-84. PubMed ID: 22729879
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
Linardou H; Kalogeras KT; Kronenwett R; Alexopoulou Z; Wirtz RM; Zagouri F; Scopa CD; Gogas H; Petraki K; Christodoulou C; Pavlakis K; Koutras AK; Samantas E; Patsea H; Pectasides D; Bafaloukos D; Fountzilas G
Anticancer Res; 2015 Jul; 35(7):4023-36. PubMed ID: 26124351
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of VEGF-C immunohistochemical expression in breast cancer: a meta-analysis.
Gao S; Ma JJ; Lu C
Tumour Biol; 2014 Feb; 35(2):1523-9. PubMed ID: 24078449
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of c-Met overexpression in breast cancer.
Zhao X; Qu J; Hui Y; Zhang H; Sun Y; Liu X; Zhao X; Zhao Z; Yang Q; Wang F; Zhang S
Oncotarget; 2017 Aug; 8(34):56758-56767. PubMed ID: 28915628
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
11. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis.
Yu L; Deng L; Li J; Zhang Y; Hu L
Gynecol Oncol; 2013 Feb; 128(2):391-6. PubMed ID: 23142075
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases.
Yan S; Jiao X; Zou H; Li K
Diagn Pathol; 2015 Jun; 10():62. PubMed ID: 26047809
[TBL] [Abstract][Full Text] [Related]
14. Combined Wnt/β-catenin, Met, and CXCL12/CXCR4 signals characterize basal breast cancer and predict disease outcome.
Holland JD; Györffy B; Vogel R; Eckert K; Valenti G; Fang L; Lohneis P; Elezkurtaj S; Ziebold U; Birchmeier W
Cell Rep; 2013 Dec; 5(5):1214-27. PubMed ID: 24290754
[TBL] [Abstract][Full Text] [Related]
15. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of vascular endothelial growth factor expression in women with ovarian cancer: A meta-analysis.
Hui G; Meng M
J BUON; 2015; 20(3):870-8. PubMed ID: 26214642
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.
Zhang Z; Luo G; Tang H; Cheng C; Wang P
PLoS One; 2016; 11(11):e0165725. PubMed ID: 27812168
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis.
Du Y; Long Q; Guan B; Mu L
Dis Markers; 2015; 2015():568980. PubMed ID: 26526157
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of vascular endothelial growth factor in patients with head and neck cancer: A meta-analysis.
Zang J; Li C; Zhao LN; Shi M; Zhou YC; Wang JH; Li X
Head Neck; 2013 Oct; 35(10):1507-14. PubMed ID: 22987573
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
Lin SC; Gan ZH; Yao Y; Min da L
PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
